DavidPaulRichmanMD

Professor, Neurology, UC, Davis School of Medicine

Dr. Richman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3160 Folsom Boulevard
UC Davis Department Of Neurology
Sacramento, CA 95816
Phone+1 916-734-3588

Fax+1 916-734-7188

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1971 - 1975
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1969 - 1971
Johns Hopkins University School of MedicineClass of 1969

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Whos Who in Medicine and Healthcare Marquis Whos Who

PubMed

38 citations
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials
Kevin M. Biglan, Ira Shoulson, Karl Kieburtz, David Oakes, Elise Kayson
JAMA Neurology. 2016-01-01
95 citations
Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
David P. Richman, James B. Patrick, Barry G. W. Arnason
The New England Journal of Medicine. 1976-03-25
103 citations
Neuromuscular transmission in amyotrophic lateral sclerosis.
Ricardo A. Maselli, Robert Wollman, Cynthia Leung, Barbara J. Distad, Sandra Palombi
Muscle & Nerve. 1993-11-01

Development Of Animal Models Of Anti-Musk MyastheniaNational Institute Of Neurological Disorders And Stroke2010–2011
IX International Conference On Myasthenia GravisNational Institute Of Neurological Disorders And Stroke1997
Pathogenic Mechanisms In MyastheniaNational Institute Of Neurological Disorders And Stroke1994–1996
Antiidiotypic Antibodies In MyastheniaNational Institute Of Neurological Disorders And Stroke1994–1995
Anti-Idiotypic Antibodies In MyastheniaNational Institute Of Neurological Disorders And Stroke1991–1993
Pathogenic Mechanisms In Myasthenia GravisNational Institute Of Neurological Disorders And Stroke1991–1992
In Vivo Effects Of Antibodies Blocking Achr Function IonNational Institute Of Neurological Disorders And Stroke1991
Core--ScientificNational Institute Of Neurological Disorders And Stroke1991
Anti-Idiotypic Antibodies In MyastheniaNational Institute Of Neurological Disorders And Stroke1985–1991
Scientific CoreNational Institute Of Neurological Disorders And Stroke1989–1990
Structure/Function Analysis Of Acchr EpitopesNational Institute Of Neurological Disorders And Stroke1987–1990
In Vivo Effects Of Antibodies Blocking Acchr Function IonNational Institute Of Neurological Disorders And Stroke1987–1990
Pathogenic Mechanisms In Myasthenia GravisNational Institute Of Neurological Disorders And Stroke1985–1990